Evidence for the Involvement of Docosahexaenoic Acid in Cholinergic Stimulated Signal Transduction at the Synapse

Neurochemical Research - Tập 22 - Trang 663-670 - 1997
Collins R. Jones1, Toshanari Arai1, Stanley I. Rapoport1
1Laboratory of Neurosciences, National Institute on Aging, National Institutes of Health, Bethesda

Tóm tắt

[4,5-3H]Docosahexaenoic acid ([3H]DHA) or [9,10-3H]palmitic acid ([3H]PAM) was infused intravenously for 5 min to awake, adult male rats before and after treatment with arecoline (15 mg/kg, i.p.), a cholinergic agonist. Animals were killed 15 min post-infusion, the brains were rapidly removed and subcellular fractions were obtained after sucrose density centrifugation. In control animals, [3H]DHA and [3H]PAM were incorporated into the synaptosomal fractions, representing 50%–60% of total membrane label. Most remaining membrane label (30%–40%) was in the microsomal fraction. Both fractions contained the synaptic marker synaptophysin. The remaining 10% of radioactivity was in the myelin and mitochondrial fractions. Arecoline significantly increased [3H]DHA entry into the synaptosomal fractions by 100% and into the microsomal fraction by 50%. In these fractions 60%–65% of the [3H]DHA was in phospholipid, the rest corresponding to free fatty acid and diacylglycerol. In contrast, arecoline did not change [3H]PAM incorporation into any brain fraction. These results demonstrate that plasma [3H]DHA incorporation is selectively increased into synaptic membrane phospholipids of the rat brain in response to cholinergic activation. The increased incorporation of DHA but not of PAM into synaptic membranes in response to cholinergic stimulation indicates a primary role for DHA in phospholipid mediated signal transduction at the synapse involving activation of phospholipase A2 and/or C.

Tài liệu tham khảo

Rouser, G., and Fleischer, S. 1969. Phospholipid composition of human, bovine and frog myelin isolated on a large scale from brain and spinal cord. Lipids 4:239–242. Mckenna, M. C., and Campagnoni, A. T. 1979. Effect of pre-and postnatal essential fatty acid deficiency on brain development and myelination. J. Nutr. 109:1195–1204. Calderaro, V., Parrillo, C., Balestrieri, M. L., Giovane, A., Filippelli, A., and Rossi, F. 1994. Docosahexaenoic acid and signaling pathways in rabbit colon. Molec. Pharmacol. 45:737–746. Kim, H. Y., Karanian, J. W., Shingu, T., and Salem, N. 1990. Stereochemical analysis of hydroxylated docosahexaenoates produced by human platelets and rat brain brain homogenate. Prostaglandins 40:43–489. Sprecher, H. 1986. The metabolism of (n-3) and (n-6) fatty acids and their oxygenation by platelet cyclooxygenase and lipoxygenase. Prog. Lipid Res. 25:19–28. van Rollins, M. 1990. Synthesis and and characterization of cytochrome P450-epoxygenase metabolites of eicosapentaenoic acid. Lipids 25:481–490. van Kuijk, F., Holte, L. L., and Dratz, E. A. 1990. 4-hydroxyhexenal: a lipid peroxidation product derived from oxidized docosahexaenoic acid. Biochim. Biophys. Acta. 1043:116–118. Oliw, E. H. 1994. Oxygenation of polyunsaturated fatty acids by cytochrome P450 monooxygenases. Prog. Lipid Res. 33:329–354. van Rollins, M. 1991. Health Effects of Omega 3 PUFAs Pages 502–521, in Simopoulus A. P., Kifer R. R., Martin R. E., Barlow C., (eds.) Seafoods, Krager, Basel. Axelrod, J., Burch, R. M., and Jelsema, C. L. 1988. Receptor-mediated activation of phospholipase A2 via GTP-binding proteins: arachidonic acid and its metabolites as second messengers. Trends Neurosci. 11:117–123. Cockcroft, S., and Thomas, G. M. H. 1992. Inositol-lipid-specific phospholipase C isoenzymes and their differential regulation by receptors. Biochem J. 288:1–14. Lapetina, E. G. 1989. Role of phospholipase C and G-proteins in signal transduction. in Phospholipids in the Nervous System: Biochemical and Molecular Pathology (Bazan N. G., Horrocks L. A., and Toffano, G. eds) Liviana Press, Padova. Robinson, P. J., Noronha, J., DeGeorge, J. J., Freed, L. M., Nariai, T., and Rapoport, S. I. 1993. A quantitative method for measuring regional in vivo fatty acid incorporation into and turnover within brain phospholipids: review and critical analysis. Brain Res. Rev. 17:187–214. Yamazaki, S., DeGeorge, J. J., Bell, J. M., and Rapoport, S. I. 1994. Effect of Pentobarbitol on incorporation of plasma palmitate into rat brain. Anesthesiology 80:151–158. Chang, M. C. J., Arai, T., Freed, L. M., Wakabayashi, S., Channing, M. A., Dunn, B. B., Der, M. G., Bell, J. M., Sasaki, T., Herscovitch, P., Eckelman, W. C., and Rapoport S. I. 1994. Brain Incorporation of [1–11C]arachidonate in normocapnic and hypercapnic monkeys, measured with positron emission tomography. Brain Research (submitted). Yamazaki, S., Noronha, J. G., Bell, J., and Rapoport, S. I. 1989. Incorporation of plasma [14C]palmitate into the hypoglossal nucleus following unilateral axotomy of the hypoglossal nerve in adult rat, with and without regeneration. Brain Res. 477:19–28. Nariai, T., DeGeorge, J. J., Greig, N. H., Genka, S., Rapoport, S. I., and Purdon, D. A. 1994. Differences in rates of incorporation of intravenously injected radiolabeled fatty acids into phospholipids of intracerebrally implanted tumor and brain in awake rats. Clin. Exp. Metastasis 12:213–225. DeGeorge, J. J., Naria, T., Yamazaki, S., Williams, W. M., and Rapoport, S. I. 1991. Arecoline-stimulated brain incorporation of intravenously administered fatty acids in unanesthized rats. J. Neurochem. 56:352–355. Jones, C. R., Arai, T., Bell, J., and Rapoport, S. I. 1995a. Selective in vivo incorporation of [3H]arachidonic acid from blood into rat brain synaptosomal fractions before and after cholinergic stimulation. J. Neurochem. 67:822–829. Sun, G. Y., Huang, H-M., Kelleher, J. A., Stubbs, E. B., and Sun, A. Y. 1988. Marker enzymes, phospholipids and acyl group composition of a somal plasma membrane fraction isolated from rat cerebral cortex: A comparison with microsomes and synaptic plasma membranes. Neurochem. Int. 12:69–77. Kishimoto, Y. L., Agranoff, B. W., Radin, N. S., and Burton, R. M. 1969. Comparison of the fatty acids of lipids of subcellular brain fractions. J. Neurochem. 16:397–405. Jones, C. R., Arai, T., and Rapoport, S. I. 1995b. Incorporation of [3H]docosahexaenoic acid into rat brain subcellular fractions: effects of cholinergic stimulation. J. Neurochem. 64(suppl):S102. Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248–257. Folch, J., Lees, M., and Sloane-Stanley, G. H. 1957. A simple method for the isolation and purification of total lipids from animal tissue. J. Biol. Chem. 226:497–509. Axelrod, J. 1990. Receptor-mediated activation of phospholipase A2 and arachidonic acid release in signal transduction. Biochem. Soc. Trans. 18:503–507. Sun, G. Y., and MacQuarrie, R. A. 1989. Deacylation-reacylation of arachidonyl groups in cerebral phospholipids. Ann. N.Y. Acad. Sci. 559:37–55. Purdon, D., Arai, T., and Rapoport, S. I. 1995. Insignificant contribution of plasma esterified palmitate to palmitate flux into brain phospholipids of the adult rat. J. Neurochem. 64(suppl):S101. Johnston, P. A., Cameron, P. L., Stukenbrok, H., Jahn, R., De Camilli, P., and Sudhof, T. C. 1989. Synaptophysin is targeted to similar microvessels in CHO and PC12 cells. The EMBO J. 8: 2863–2872. Sun, G. Y., and Yau, T. M. 1976. Incorporation of [1-14C]oleic Acid and [1-14C] arachidonic acid into lipids in subcellular fractions of mouse brain. J. Neurochem. 27:87–92. Sun, G. Y. 1977. Metabolism of arachidonate and stearate injected simultaneously into the mouse brain. Lipids 12:661–665. Mayer, R. J., and Marshall, L. A. 1993. New insights on mammalian phospholipase A2(s); comparison of arachidonyl-selective and-nonselective enzymes. FASEB J. 7:339–348. Rhee, S. G., and Choi, K. D. 1992. Regulation of inositol phospholipid specific phospholipase C isozymes J. Biol. Chem. 267: 12393–2396. Meldrum, E., Parker, P. J., and Carozzi, A. 1991. The Ptdlns-PLC superfamily and signal transduction. Biochim. Biophys. Acta. 1092:49–71. Shinkano, M., Masuzawa, Y., Yazawa, K., Takayama, K., Kudo, I., and Inoue, K. 1994. Complete discrimination of docosahexaenoate from arachidonate by 85 kDa cytosolic PLA2 during the hydrolysis of diacyl-and alkenylacylglycerophosphoethanolamine. Biochim. Biophys. Acta. 1212:211–216. Rao, G. H., Radda, E., and White, J. G. 1983. Effect of docosahexaenoic acid (DHA) on arachidonic acid metabolism and platelet function. Biochem. Biophys. Res. Comm. 117:549–555. Corey, E. J., Shih, C., and Cashman, J. R. 1983. Docosahexaenoic acid is a strong inhibitor of prostaglandin but not leukotriene biosynthesis. Proc. Nat. Acad. Sci. (USA) 80:3581–3584. Washizaki, K., Smith, Q. R., Rapoport, S. I., and Purdon, A. D. 1994. Brain arachidonic acid incorporation during intravenous infusion of unesterified [3H]arachidonate in the anesthetized rat. J. Neurochem. 63:727–736. Shetty, H. U., Purdon, A. D., and Rapoport, S. I. 1993. Arachidonate molecular species of rat brain PC and PI. Trans. Amer. Soc. Neurochem. 25:296. Grange, E., Deutsch, J., Smith, Q. R., Chang, M., Rapoport, S. I., and Purdon, A. D. 1995. Specific activity of brain palmitoyl-CoA provides rates of incorporation of palmitate in brain phospholipids in awake rats. J. Neurochem. 65:2290–2298. Gnaedinger, J. M., Miller, J. C., Latker, C. H., and Rapoport, S. I. 1988. Cerebral metabolism of plasma [14C]palmitate in awake, adult rat: subcellular localization. Neurochem. Res. 13:21–29. Sun, G. Y., and Horrocks, L. A. 1973. Metabolism of palmitic acid in the subcellular fractions of mouse brain. J. Lipid Res. 14: 206–214.